Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: New Zealand Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20091
20102
20111
20123
20133
20151
20171
20184
20193
20201
20214
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting4
Terminated4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Bristol-Myers Squibb3
Exelixis3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
National Medical Research Council (NMRC), Singapore2
ABK Biomedical1
Abbott1
Apollomics (Australia) Pty. Ltd.1
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular32
Liver Neoplasms10
Neoplasms4
Carcinoma3
Carcinoma, Renal Cell3
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Liver Diseases2
Adenocarcinoma1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.